Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Mar. 2026,
Hipromine paidzł0.00 Mil more to buy back shares than it received from issuing new shares.
It spentzł6.81 Mil paying down its debt.
It paidzł0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.
It receivedzł0.00 Mil from paying cash dividends to shareholders.
It spentzł2.10 Mil on other financial activities.
In all, Hiprominespentzł8.91 Mil on financial activities for the
three
months ended in Mar. 2026.
Hipromine (WAR:HPM) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Hipromine's issuance of stock for the
three
months ended in Mar. 2026 was zł0.00 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Hipromine's repurchase of stock for the
three
months ended in Mar. 2026 was zł0.00 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Hipromine's net issuance of debt for the
three
months ended in Mar. 2026 was zł-6.81 Mil.
Hipromine spentzł6.81 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Hipromine's net issuance of preferred for the
three
months ended in Mar. 2026 was zł0.00 Mil.
Hipromine paidzł0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Hipromine's cash flow for dividends for the
three
months ended in Mar. 2026 was zł0.00 Mil.
Hipromine receivedzł0.00 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Hipromine's other financing for the
three
months ended in Mar. 2026 was zł-2.10 Mil.
Hipromine spentzł2.10 Mil on other financial activities.
Hipromine Cash Flow from Financing Related Terms
Hipromine Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Hipromine's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Hipromine's Cash from Financing for the fiscal year that ended in Dec. 2025 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł22.35 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of zł22.35 Mil mean?
Hipromine (WAR:HPM) has a Cash Flow from Financing of zł22.35 Mil as of Mar. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Hipromine and its competitors.
Is Hipromine's Cash Flow from Financing too high?
Hipromine's current Cash Flow from Financing is zł22.35 Mil. Overall, Hipromine has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hipromine's Cash Flow from Financing compare to KHC and GIS?
Hipromine's Cash Flow from Financing of zł22.35 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Consumer Packaged Goods company?
A good Cash Flow from Financing depends on the Consumer Packaged Goods industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Hipromine and its competitors. Hipromine's current Cash Flow from Financing is zł22.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hipromine stock overvalued right now?
Based on GuruFocus' analysis, Hipromine (WAR:HPM) is currently considered Possible Value Trap. The stock's GF Value™ is zł868.81, compared to a current price of zł73.00 — trading 91.6% below its estimated fair value. The current Cash Flow from Financing is zł22.35 Mil. Hipromine's overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Hipromine (WAR:HPM), the current Cash Flow from Financing is zł22.35 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hipromine (WAR:HPM) Overvalued in 2026?
Based on GuruFocus' analysis, Hipromine stock appears to be undervalued.
The current stock price of zł73.00 is trading 91.6% below its estimated GF Value™ of zł868.81.
GuruFocus considers Hipromine to be Possible Value Trap.
Key valuation signals for WAR:HPM:
Cash Flow from Financing: zł22.35 Mil
GF Value™: zł868.81 vs. price of zł73.00 (91.6% below fair value)
No single metric tells the full story. See the WAR:HPM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hipromine SA is a European scale supplier of an alternative protein produced through innovative, proprietary technology of industrial insect breeding. The company's offer is directed mainly to the market of pet food and fodder for fish farming, as well as livestock and horticulture.
52GF Score
Get the complete analysis for WAR:HPM
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:HPM has been successfully added to your 
